文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

埃塞俄比亚卫生专业人员接种Mpox疫苗的意愿及相关因素:一项横断面研究

Willingness to take Mpox vaccine and associated factors among health professionals in Ethiopia: A cross-sectional study.
PubMed 文献 · Vaccine · 2025-01-31

2024年8月31日至9月6日对埃塞俄比亚749名卫生专业人员开展全国在线横断面调查,仅211人(28.2%)表示愿意接种Mpox疫苗;近期前往Mpox疫情国家、对疫苗持积极态度、缺乏感染信息获取途径、认为避免治疗Mpox病例可防自身污染及既往接触新冠确诊病例与接种意愿显著相关。

要点

  • 749名卫生专业人员中仅211人(28.2%)愿意接种Mpox疫苗。
  • 近期前往Mpox疫情国家者接种意愿更高(AOR=3.21,95%CI:1.65-6.29)。
  • 对Mpox疫苗持积极态度者接种意愿更高(AOR=3.08,95%CI:2.11-4.49)。

核心结论

  • 尽管该大陆持续存在疫情,仅低比例的受访卫生专业人员表示愿意接种Mpox疫苗。
  • 在应对疫情时,制定和分发Mpox疫苗信息需考虑近期前往疫情国家、对Mpox的态度、疾病知识及既往接触新冠确诊病例等因素。
  • 需投入大量努力教育和赋能埃塞俄比亚卫生专业人员,以有效参与防控措施。

研究设计与样本

  • 2024年8月31日至2024年9月6日开展的全国在线横断面研究。
  • 采用目的抽样结合滚雪球抽样招募卫生专业人员,使用半结构化在线调查工具,工具经预测试且所有条目设为必填,剔除针对目标问卷误答的应答后仅纳入字符正确的数据。
  • 共纳入749名卫生专业人员;双变量 logistic 回归中 p<0.25 的变量进入多变量分析,计算调整比值比(AOR)及95%置信区间(CI),最终模型以 p<0.05 为统计学显著。

主要发现

  • 637名(85%)参与者为男性,674名(90%)目前在城市地区就业,543名(72.5%)曾接种COVID-19疫苗。
  • 423名(56.5%)对Mpox有良好知识,211名(28.2%)表示愿意接种Mpox疫苗。
  • 近期前往经历Mpox疫情的国家与接种意愿显著相关(AOR=3.21,95%CI:1.65-6.29)。
  • 对Mpox疫苗 uptake 持积极态度与接种意愿显著相关(AOR=3.08,95%CI:2.11-4.49)。
  • 缺乏获取Mpox感染信息的途径(AOR=1.93,95%CI:1.05-3.55)、认为避免治疗Mpox病例可防止自身污染(AOR=4.05,95%CI:2.83-5.80)及既往接触新冠确诊病例(AOR=1.57,95%CI:1.07-2.32)与接种意愿显著相关。

临床怎么用

  • 在应对疫情期间制定和分发Mpox疫苗信息时,作者认为应考虑近期前往Mpox疫情国家、对Mpox的态度、疾病知识及既往接触新冠确诊病例等因素。
  • 作者认为需投入大量努力教育和赋能埃塞俄比亚卫生专业人员,以有效参与防控措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Monkeypox (Mpox) is vaccine preventable a viral infection declared as a public health emergency of international concern by the World Health Organization in 2022. As a response to the epidemic, vaccines against the virus are being implemented in different countries, complementing other public health interventions. However, little is known about the willingness to accept the Mpox vaccine among health professionals in Africa, notably in Ethiopia. Therefore, this study aimed to identify willingness to take the Mpox vaccine and associated factors among health professionals in Ethiopia. METHODS: A national online cross-sectional study design was employed between August 31, 2024, and September 6, 2024, among health professionals in Ethiopia. The data were collected from purposively selected healthcare professionals utilizing snowball sampling to achieve a high response rate using a semi-structured online survey tool. The tool was pretested, every survey item was drafted as a must-fill, and only data with correct characters were included after removing responses with miss response for the intended questionnaire. Variables with a p-value<0.25 in the bivariable logistic regression analysis were taken as candidates for multivariable analysis. An adjusted odds ratios (AORs) with 95 % confidence interval (CI) were computed and p-value <0.05 were used to set statistically significant variables within final model. Finally, text, tables, and figures were used to present the data. RESULTS: The study involved 749 health professionals. Of the participants, 637 (85 %) were males, 674 (90 %) were currently employed in urban areas, and 543 (72.5 %) had received the COVID-19 vaccine. Among all participants, 423 (56.5 %) demonstrated a good knowledge of Mpox, whereas 211 (28.2 %) expressed a willingness to get vaccinated against Mpox. Besides, recent travel to countries experiencing the Mpox outbreak (AOR = 3.21, 95 %CI:1.65-6.29), positive attitude towards the Mpox vaccine uptake (AOR = 3.08, 95 %CI:2.11-4.49), lack of access to Mpox infection information (AOR = 1.93, 95 %CI:1.05-3.55), the belief that avoiding treatment of Mpox cases would prevent self-contamination (AOR = 4.05, 95 %CI: 2.83-5.80), and prior contact with individuals diagnosed with COVID-19 (AOR = 1.57 95 %CI (1.07-2.32)were factors significantly associated with willingness to get vaccinated against Mpox. CONCLUSIONS: Despite the ongoing outbreak within the continent, only a low proportion of surveyed health professionals expressed willingness to receive the Mpox vaccine. In addressing the outbreak, it is crucial to consider various factors such as recent travel to Mpox-affected countries, attitude towards Mpox, knowledge about the disease, and prior exposure to confirmed COVID-19 cases when developing and distributing information about Mpox vaccine. Consequently, substantial efforts must be directed towards educating and empowering health professionals in Ethiopia to effectively contribute to prevention and control measures.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fetensa G, Tolossa T, Besho M, et al. Willingness to take Mpox vaccine and associated factors among health professionals in Ethiopia: A cross-sectional study. Vaccine. 2025. PMID: 39892112. doi:10.1016/j.vaccine.2025.126822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。